We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement

We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement

Clinical Practice Guidelines

COVID-19 Guidance

The NCCP have developed a number of guidance documents that are available here and in the HSE COVID-19 Clinical Guidance and Evidence Repository https://hse.drsteevenslibrary.ie/Covid19V2/cancercare

National Clinical Guidelines

The Cancer Strategy 2006 recommended that national site-specific multi-disciplinary groups should be convened to develop evidence based guidelines for common cancers.

Evidence-based guidelines:

  • Aim to improve the quality of clinical care
  • Aim to prevent variation in practice
  • Are based on the best research evidence in conjunction with clinical expertise

The National Cancer Control Programme (NCCP) is developing national evidence-based clinical guidelines for the diagnosis, staging and treatment of common cancers, through its "Guideline Development Groups" commencing with:

Evidence into practice - rapid reviews

Last updated 20th December 2018